Fierce Biotech
Behind the curtain: What Xaira is building after its $1B fundraise
What has Xaira been doing since its $1 billion raise? Xaira COO Jeff Jonker joins “The Top Line” to talk strategy, AI and the company’s long-game vision for drug discovery.